|
IPO4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.393000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.242400E-01 |
| Normal-vs-Stage2 |
4.233400E-04 |
| Normal-vs-Stage3 |
2.077800E-02 |
| Normal-vs-Stage4 |
3.816200E-01 |
| Stage1-vs-Stage2 |
4.78960000005468E-06 |
| Stage1-vs-Stage3 |
8.001700E-04 |
| Stage1-vs-Stage4 |
1.428370E-01 |
| Stage2-vs-Stage3 |
1.657230E-01 |
| Stage2-vs-Stage4 |
2.135900E-02 |
| Stage3-vs-Stage4 |
2.283600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.259620E-01 |
| Normal-vs-AfricanAmerican |
4.024200E-01 |
| Normal-vs-Asian |
7.079800E-01 |
| Caucasian-vs-AfricanAmerican |
3.167600E-02 |
| Caucasian-vs-Asian |
4.460800E-01 |
| AfricanAmerican-vs-Asian |
9.251800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.471900E-02 |
| Normal-vs-Female |
6.591600E-01 |
| Male-vs-Female |
2.778300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.482600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.011600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.692600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.681580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.723400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.232000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.181400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.971000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.347600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.705200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.622230E-01 |
| Normal-vs-Grade 2 |
9.525000E-01 |
| Normal-vs-Grade 3 |
1.437770E-01 |
| Normal-vs-Grade 4 |
1.508470E-02 |
| Grade 1-vs-Grade 2 |
2.385200E-01 |
| Grade 1-vs-Grade 3 |
7.340300E-02 |
| Grade 1-vs-Grade 4 |
6.141200E-03 |
| Grade 2-vs-Grade 3 |
9.369800E-02 |
| Grade 2-vs-Grade 4 |
6.399000E-03 |
| Grade 3-vs-Grade 4 |
1.994200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.170000E-01 |
| Normal-vs-ccB subtype |
5.062600E-03 |
| ccA subtype-vs-ccB subtype |
1.019750E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.027600E-01 |
| Normal-vs-N1 |
1.883610E-02 |
| N0-vs-N1 |
5.896100E-02 |
|
|
